Too many tumours are sadly found too late - at B4-RNA, we are developing a new liquid biopsy diagnostic to fight cancer by catching it before symptoms arrive, giving patients an opportunity to access effective early treatment options. We have developed and patented a unique RNA repair and sequencing method that allows us to see a broader set of RNA molecules in blood - our objective is to use this technology to identify cancer patterns for some of the most devastating cancers, and develop a diagnostic tool that is accessible to all. B4-RNA is powered by LAB+ Company Builder and incubated at…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.